Literature DB >> 34604788

Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19.

Madhav V Dhodapkar1,2, Kavita M Dhodapkar2,3, Rafi Ahmed2,4.   

Abstract

Patients with hematologic malignancies have increased susceptibility to viral infections and suboptimal immunologic responses to current vaccines due to both disease-associated and therapy-related immune dysfunction. These considerations may impact the efficacy of emerging COVID-19 vaccines in this patient population as well and warrant the need to systematically study natural and vaccine-induced virus-specific immunity in these patients.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 34604788      PMCID： PMC8486288          DOI： 10.1158/2643-3230.bcd-20-0177

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN： 2643-3230


  13 in total

Review 1.  Chemotherapy and Beyond: Infections in the Era of Old and New Treatments for Hematologic Malignancies.

Authors:  Sarah Atkins; Fiona He
Journal:  Infect Dis Clin North Am       Date:  2019-03-30       Impact factor: 5.982

Review 2.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

3.  Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial.

Authors:  Andrew R Branagan; Eamon Duffy; Randy A Albrecht; Dennis L Cooper; Stuart Seropian; Terri L Parker; Geliang Gan; Fangyong Li; Daniel Zelterman; Chandra Sekhar Boddupalli; Lin Zhang; Rakesh Verma; Thomas M Ferencz; Madhav V Dhodapkar
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-03-07

4.  The COVID-19 Pandemic in the US: A Clinical Update.

Authors:  Saad B Omer; Preeti Malani; Carlos Del Rio
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

5.  Determinants of COVID-19 disease severity in patients with cancer.

Authors:  Ying Taur; Mini Kamboj; Elizabeth V Robilotti; N Esther Babady; Peter A Mead; Thierry Rolling; Rocio Perez-Johnston; Marilia Bernardes; Yael Bogler; Mario Caldararo; Cesar J Figueroa; Michael S Glickman; Alexa Joanow; Anna Kaltsas; Yeon Joo Lee; Anabella Lucca; Amanda Mariano; Sejal Morjaria; Tamara Nawar; Genovefa A Papanicolaou; Jacqueline Predmore; Gil Redelman-Sidi; Elizabeth Schmidt; Susan K Seo; Kent Sepkowitz; Monika K Shah; Jedd D Wolchok; Tobias M Hohl
Journal:  Nat Med       Date:  2020-06-24       Impact factor: 53.440

Review 6.  Viral infections in patients with hematological malignancies.

Authors:  James C Wade
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

Review 7.  SARS-CoV-2 vaccines in development.

Authors:  Florian Krammer
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

8.  Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination.

Authors:  Carl W Davis; Katherine J L Jackson; Megan M McCausland; Jaime Darce; Cathy Chang; Susanne L Linderman; Chakravarthy Chennareddy; Rebecca Gerkin; Shantoria J Brown; Jens Wrammert; Aneesh K Mehta; Wan Cheung Cheung; Scott D Boyd; Edmund K Waller; Rafi Ahmed
Journal:  Science       Date:  2020-08-13       Impact factor: 47.728

9.  Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.

Authors:  Mehul S Suthar; Matthew G Zimmerman; Robert C Kauffman; Grace Mantus; Susanne L Linderman; William H Hudson; Abigail Vanderheiden; Lindsay Nyhoff; Carl W Davis; Oluwaseyi Adekunle; Maurizio Affer; Melanie Sherman; Stacian Reynolds; Hans P Verkerke; David N Alter; Jeannette Guarner; Janetta Bryksin; Michael C Horwath; Connie M Arthur; Natia Saakadze; Geoffrey H Smith; Srilatha Edupuganti; Erin M Scherer; Kieffer Hellmeister; Andrew Cheng; Juliet A Morales; Andrew S Neish; Sean R Stowell; Filipp Frank; Eric Ortlund; Evan J Anderson; Vineet D Menachery; Nadine Rouphael; Aneesh K Mehta; David S Stephens; Rafi Ahmed; John D Roback; Jens Wrammert
Journal:  Cell Rep Med       Date:  2020-06-08

10.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850
View more
  8 in total

1.  It takes T to tango: immunotherapy in MM.

Authors:  Vikas A Gupta; Madhav V Dhodapkar
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

2.  How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.

Authors:  Antoni Ribas; Madhav V Dhodapkar; Katie M Campbell; Faith E Davies; Steven D Gore; Ronald Levy; Lee M Greenberger
Journal:  Blood Cancer Discov       Date:  2021-09-15

Review 3.  COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response.

Authors:  Ivan Gur; Amir Giladi; Yonathan Nachum Isenberg; Ami Neuberger; Anat Stern
Journal:  Acta Haematol       Date:  2022-03-02       Impact factor: 3.068

4.  Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.

Authors:  Jing Sun; Qulu Zheng; Vithal Madhira; Amy L Olex; Alfred J Anzalone; Amanda Vinson; Jasvinder A Singh; Evan French; Alison G Abraham; Jomol Mathew; Nasia Safdar; Gaurav Agarwal; Kathryn C Fitzgerald; Namrata Singh; Umit Topaloglu; Christopher G Chute; Roslyn B Mannon; Gregory D Kirk; Rena C Patel
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 44.409

5.  Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.

Authors:  Kavita M Dhodapkar; Madhav V Dhodapkar; Akhilesh Kaushal; Ajay K Nooka; Allison R Carr; Katherine E Pendleton; Benjamin G Barwick; Julia Manalo; Samuel S McCachren; Vikas A Gupta; Nisha S Joseph; Craig C Hofmeister; Jonathan L Kaufman; Leonard T Heffner; Stephen M Ansell; Lawrence H Boise; Sagar Lonial
Journal:  Blood Cancer Discov       Date:  2021-09-01

6.  Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Authors:  Andres Chang; Akil Akhtar; Susanne L Linderman; Lilin Lai; Victor M Orellana-Noia; Rajesh Valanparambil; Hasan Ahmed; Veronika I Zarnitsyna; Ashley A McCook-Veal; Jeffrey M Switchenko; Jean L Koff; Kristie A Blum; Amy A Ayers; Colin B O'Leary; Michael C Churnetski; Shahana Sulaiman; Melissa Kives; Preston Sheng; Carl W Davis; Ajay K Nooka; Rustom Antia; Madhav V Dhodapkar; Mehul S Suthar; Jonathon B Cohen; Rafi Ahmed
Journal:  J Clin Oncol       Date:  2022-04-18       Impact factor: 50.717

7.  Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis.

Authors:  Mohammad-Mehdi Mehrabi Nejad; Fatemeh Moosaie; Hojat Dehghanbanadaki; Abdolkarim Haji Ghadery; Mahya Shabani; Mohammadreza Tabary; Armin Aryannejad; SeyedAhmad SeyedAlinaghi; Nima Rezaei
Journal:  Eur J Med Res       Date:  2022-02-12       Impact factor: 2.175

8.  Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.

Authors:  Ajay K Nooka; Uma Shanmugasundaram; Narayana Cheedarla; Hans Verkerke; Venkata V Edara; Rajesh Valanparambil; Jonathan L Kaufman; Craig C Hofmeister; Nisha S Joseph; Sagar Lonial; Maryam Azeem; Julia Manalo; Jeffrey M Switchenko; Andres Chang; Susanne L Linderman; John D Roback; Kavita M Dhodapkar; Rafi Ahmed; Mehul S Suthar; Andrew S Neish; Madhav V Dhodapkar
Journal:  J Clin Oncol       Date:  2022-03-08       Impact factor: 50.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.